- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- Boomers' Biggest Retirement Regret? They Didn't Work Longer
- The 10 Poorest States in America
The $672 million deal positions the buyer to serve the self-driving car market and preempts a planned restructuring by the seller.
Endo's deal preempts Par Pharmaceutical's planned IPO and will create a top generic drugmaker.
Swiss agricultural chemicals maker Syngenta AG on Friday, May 8, said its board has rejected a long-rumored, unsolicited $45.2 billion takeover approach from seed giant Monsanto.
The Redwood City, Calif. data-center operator argues that its $3.5 billion proposal is better for TeleCity's shareholders.
Australian telecom iiNet on Wednesday recommended shareholders accept a sweetened A$1.56 billion ($1.24 billion) takeover proposal from TPG that matches a rival cash-and-stock bid from M2 Group.
Nokia defended the price it offered for French rival Alcatel-Lucent as unexpectedly weak first-quarter earnings prompted a sell-off that eroded the value of the all-stock bid.
Arris is expanding its video services.
The acquisitive cable company Liberty Global has bought its own cellular network, Base, in Belgium. The deal could be the start of something bigger.
Generic-drug company Mylan goes on the offensive to counter persistent speculation about a pending bid from Israeli rival Teva Pharmaceutical Industries.
French President Francois Hollande and Economy Minister Emmanuel Macron both 'welcomed' the deal, Alcatel's CEO said.